At RCRI, we are scientists first — committed to the highest standards of professional excellence in CRO research and clinical trials. There are some CROs that have been around for a while, but none that have also delivered the most accurate, efficient, and sophisticated clinical research consulting services PLUS an integrated consulting partnership since 1999 like RCRI.
Trial designs and execution require thoughtful planning to achieve the most efficient acquisition of sound scientific evidence.
Our collaborative approach, and creative problem solving can save you time and money during the operational phase of your project. We support our clients with:
An experienced team makes all the difference in the success of your study. Our advisors’ breadth of expertise covers medical device clinical strategy, trial design, operationalization, data management, clinical compliance, biostatistics and medical writing. Using our deep experience in both premarket and post market studies, we can quickly pinpoint areas for improvement or efficiency, identify unusual findings in the data, and work with you to anticipate and overcome challenges, while obtaining the necessary evidence at the right time in your product lifecycle.
“RCRI has been outstanding to work with from the beginning. They shared our commitment and dedication for conducting a high-quality, FDA-regulated clinical study and did so in a collaborative and results-oriented fashion. We very much appreciate the role RCRI has played.”
– CEO and President, Spinal Biologic Device
Integrated strategy + Flawless execution + Compelling evidence
Maximizing the success of a clinical trial requires an integration of regulatory know-how with business savvy and a focus on flawless execution. As a result, our studies generate compelling evidence demonstrating value for all stakeholders in the timeframe that meets or even beats your schedule.
RCRI is a clinical research partner that brings a higher value to your entire evidence development process.
Overcoming remediation challenges while keeping operations running
After buying a long-established medical device manufacturer, this large multinational corporation found major shortcomings in quality systems and regulatory affairs strategies after an internal audit. They knew they had to immediately develop complete, harmonized quality systems in order to avoid regulatory findings.